Background Laparoscopic distal pancreatectomy (LDP) is increasingly performed for lesions of the body and tail of the pancreas. The aim of this study was to investigate short-term outcomes after LDP compared to open distal pancreatectomy (ODP) at a single, high-volume institution. Methods We reviewed records of patients who underwent distal pancreatectomy (DP) and compared perioperative data between LDP and ODP. Continuous variables were compared using Student's t or Wilcoxon rank-sum tests. Categorical variables were compared using chi-square or Fisher's exact test. Results A total of 360 patients underwent DP. Beginning in 2001, 95 were attempted, and 71 were completed laparoscopically with a 25.3% conversion rate. Compared to ODP, LDP had similar rates of splenic preservation, pancreatic fistula, and mortality. LDP had lower blood loss (150 vs. 900 mL, p<0.01), smaller tumor size (2.5 vs. 3.6 cm, p<0.01), and shorter length of resected pancreas (7.7 vs. 10.0 cm, p<0.01). LDP had fewer complications (28.2% vs. 43.8%, p=0.02) as well as shorter hospital stays (5 vs. 6 days, p<0.01). Conclusions LDP can be performed safely and effectively in patients with benign or low-grade malignant neoplasms of the distal pancreas. When feasible in selected patients, LDP offers fewer complications and shorter hospital stays.
Introduction
The laparoscopic approach continues to gain acceptance as an option for the surgical management of diseases of the distal pancreas. After initial reports in the mid-1990s, [1] [2] [3] [4] several small series began to emerge in the literature documenting the safety and feasibility of laparoscopic distal pancreatectomy (LDP). [5] [6] [7] [8] [9] Although prospective, randomized trials are lacking, a growing number of single-and multi-institution case series affirm the benefits of LDP vs. open distal pancreatectomy (ODP). [10] [11] [12] [13] We herein report a large, single-institution series of distal pancreatectomy (DP) and compare differences in clinical outcomes between the laparoscopic and open approaches.
Materials and Methods
We performed a retrospective review of a prospectively maintained database of patients with pancreatic disease. The database is maintained by The Pancreas Center of Columbia University Medical Center (CUMC) and includes the patients of four surgeons (J.A., J.C., J.L., and B.S.). After approval from the Institutional Review Board and in compliance with the Health Insurance Portability and Accountability Act regulations, we queried our database to identify all patients who underwent DP at CUMC from 1991 through 2009.
For the purposes of comparing LDP to ODP, we used inclusion and exclusion criteria to define each group as follows. We included only those patients who underwent LDP or ODP during the same time period, beginning with the first attempted LDP in 2001. For the LDP group, we excluded patients who underwent laparoscopic-assisted DP, which was defined as the preoperative plan to perform only part of the operation laparoscopically prior to laparotomy. For the ODP group, we excluded patients who underwent DP as part of a completion pancreatectomy as well as those who underwent concomitant portomesenteric venous resection and reconstruction. We also excluded patients who underwent DP secondary to debridement for necrotizing pancreatitis, oncologic resection for non-pancreatic primary neoplasms invading the pancreas, and pancreatic injury during another operation. We included the laparoscopicconverted-to-open procedures in the ODP group for all statistical analyses except for the subsets in which the LDP, ODP, and converted groups were examined independently.
Descriptive data were collected by review of patients' medical records. Preoperative variables included age, gender, race, and significant comorbidity, defined as the presence of coronary artery disease (CAD), chronic obstructive pulmonary disease (COPD), diabetes mellitus (DM), or chronic kidney disease (CKD). Intraoperative variables were obtained from nurse, anesthesiologist, and surgeon reports. Operating room (OR) time was defined as the time between patient entry into and exit from the OR. Anesthesia time was defined as the time between start of anesthesia care in the OR and patient exit from the OR. Incision time was defined as the time between incision start and incision close. Pathologic diagnosis, greatest lesion diameter, length of resected pancreas, margin status, and regional lymph node status were determined from final pathology reports. Perioperative complications were gathered from daily progress notes and discharge summaries and graded using the system proposed by DeOliveira et al. 14 Overall morbidity was defined as any complication, and major morbidity was defined as complications grade III and greater. Pancreatic fistula was assessed and graded according to the International Study Group on Pancreatic Fistula recommendations. 15 Length of stay (LOS) was calculated from date of operation to date of hospital discharge. Readmission rate was defined as readmission within 30 days of hospital discharge. Perioperative mortality was defined as death within 30 days of the operation or within the same hospital admission as the operation.
All operations were performed by four pancreatic surgeons (J.A., J.C., J.L., and B.S.) using our institution's standardized technique. For the laparoscopic cases, a fourport technique was used with 5-, 10-, and 12-mm trocars in varying combinations at the surgeon's discretion. 
Patient Characteristics
There were no statistically significant differences in demographics and preoperative comorbidities between the LDP and ODP groups. The mean age was 58.2±14.1 years in the LDP group and 60.2±15.2 years in the ODP group (p=0.36). There were 49 (69%) women and 22 (31%) men in the LDP group and 119 (62%) women and 73 (38%) men in the ODP group, with the majority being Caucasian in both groups. The incidences of CAD, COPD, DM, and CKD were similar between the two groups (Table 1) .
Intraoperative Characteristics
Intraoperative ultrasound was used to identify lesions in 37 (52.1%) LDP cases and 83 (43.2%) ODP cases (p=0.20). Various methods were employed to control the distal pancreatic remnant in both groups. Stapler and bio-sealant were used most commonly in the LDP group (77.5%), whereas suture (44.8%) and stapler with bio-sealant (39.1%) were most common in the ODP group. The rates of splenic preservation were similar in both groups (15.5% vs. 15.6%, p=0.93). Patients had lower median blood loss in the LDP group (150 mL; IQR, 100-250 mL) compared to the ODP group (900 mL; IQR, 400-1,400 mL; p<0.01). Operative drains were placed with comparable frequency in both groups (56.3% vs. 67.2%, p=0.10). Table 2 ).
Postoperative Outcomes
Patients in the LDP group had fewer overall complications (28.2% vs. 43.8%, p=0.02) and fewer major complications (8.5% vs. 18.8%, p=0.04) than those in the ODP group. There were no statistically significant differences in overall pancreatic fistula rate (11.3% vs. 14.1%, p=0.55) and clinically significant pancreatic rate (7% vs. 12.5%, p= 0.27) between the LDP and ODP groups. There were no statistically significant differences in rates of reoperation (5.6% vs. 3.6%, p=0.50) and readmission (4.2% vs. 8.9%, p=0.30) between the groups. Patients in the LDP group had shorter median LOS compared to those in the ODP group (5 days; IQR, 4-6 vs. 6 days; IQR, 5-8 days; p<0.01). Nineteen (26.8%) patients vs. 118 (61.5%) patients had median LOS longer than 5 days (p<0.01). The mortality rate was nil in the LDP group vs. 1% in the ODP group (p= 1.00; Table 3 ). In a subset analysis of spleen-preserving DP vs. en bloc DP with splenectomy, there were no statistically significant differences in morbidity, pancreatic fistula, LOS, and mortality (Table 4) .
Final Pathology
Sixty-two (87.3%) patients had benign pathology in the LDP group vs. 118 (61.5%) in the ODP group (p<0.01). Nine (12.7%) patients had malignant pathology in the LDP group vs. 74 (38.5%) in the ODP group (p<0.01). The laparoscopic approach was less likely to be used for pancreatic ductal adenocarcinoma (4.2% vs. 30.2%, p< 0.01). Patients in the LDP group had shorter average length of pancreas resected (7.7±3.2 vs. 10.0±3.6 cm, p<0.01) for smaller median tumor size (2.5 cm; IQR, 1.5-4.0 vs. 3.6 cm; IQR, 2.0-6.0 cm; p<0.01) than patients in the ODP group. The median number of lymph nodes resected was similar between both groups (6; IQR, 2.5-12.0 vs. 8; IQR, 3.0-13.0; p=0.29). The number of patients with positive lymph nodes was 6 (8.5%) in the LDP group vs. 36 (18.8%) in the ODP group (p=0.04). Two (2.8%) patients had positive margins in the LDP group vs. 25 (13%) patients in the ODP group (p=0.01). Of the two patients with positive margins in the LDP group, one had a lowgrade nonfunctional pancreatic neuroendocrine neoplasm, and one had pancreatic ductal adenocarcinoma on final pathology (Table 5) .
Laparoscopic-to-Open Conversion
Reasons for conversion included nine (37.5%) bleeding, seven (29.1%) adherent tumor, four (16.6%) difficult anatomy, one (4.2%) abdominal adhesions, one (4.2%) difficult localization of tumor, one (4.2%) enterotomy, and one (4.2%) large tumor. Of the converted cases, seven (Table 6) . When compared separately to the patients who had open DP, the converted cases had significantly longer median OR, anesthesia, and incision times, but were statistically similar with regard to pathology and postoperative outcomes ( Table 7) .
Discussion
The laparoscopic approach is being used with increasing frequency for the surgical management of pancreatic disease, particularly benign or low-grade disease of the distal body and tail. Laparoscopic distal pancreatic resection was first reported by Cuschieri in 1994 1 and later described by Gagner in 1996. 4 Since then, a growing body of case reports and single-and multi-institution series suggest that LDP can be performed with morbidity and mortality rates comparable to those of ODP and with the added benefit of shorter hospital stays. [5] [6] [7] [8] [9] [10] [11] [12] 16 19 who compared 93 LDP cases to 35 ODP cases, all performed by a single surgeon. Morbidity, mortality, and pancreatic fistula rates were similar in both groups, but the LDP group had shorter time to start of oral intake (2.8 vs. 4.5 days; p<0.001) and shorter hospital stays (10 vs. 16 days; p < 0.01). The largest multiinstitution series we encountered was by Kooby et al. 20 who compared 159 LDP patients to 508 ODP patients using data from eight different institutions. The authors reported no differences in operative times or pancreatic fistula rates between the LDP and ODP groups, but reported less blood loss (357 vs. 588 mL, p<0.01), fewer complications (40% vs. 57%, p < 0.01), and shorter hospital stays (5.9 vs. 9.0 days, p<0.01). Other large series in the literature demonstrate similar LDP outcomes, but without comparison to the open approach. 10, 21, 22 Our study is a large, single-institution retrospective series that evaluates the laparoscopic and open approaches to DP performed during the same time period. We excluded several cases from the ODP group based on procedure-specific characteristics and oncologic principles for a more accurate comparison to LDP. A patient who has an open distal pancreatic resection as part of a debridement for necrotizing pancreatitis, for example, should not be compared to a patient who has a LDP for an isolated lesion. Likewise, a patient who has an open distal pancreatic resection for an invasive adrenal cortical carcinoma should not be included. We included the laparoscopic-converted-to-open patients in the ODP group because they more closely resemble the open cases with regard to every variable except operative time. After inclusion and exclusion, the LDP and ODP groups were statistically similar with regard to demographics and preoperative comorbidities, further validating the comparison.
Our laparoscopic-to-open conversion rate of 25.3% is higher than those in the literature. Kooby et al. 20 reported a 13% conversion rate, and a recent meta-analysis by BorjaCacho et al. 13 cited a 9.2% conversion rate. At our institution, we are relatively aggressive with use of the laparoscopic approach to distal pancreatic disease because of measurable patient benefit. Although the conversion prolongs operative times, it does not affect LOS or morbidity, mortality, and pancreatic fistula rates when compared to traditional ODP. We continue to refine our preoperative selection criteria to maximize success with the laparoscopic approach, and our rate of conversion has steadily declined in recent years (Fig. 1) .
Our rates of splenic preservation with both LDP (15.5%) and ODP (15.6%) are lower than those in the literature. Recent series in the literature report rates of splenic preservation that range from 31% to as high as 85% in select cases of benign and low-grade neoplasms using the laparoscopic approach. 23 Conventional DP includes splenectomy and is the procedure of choice to achieve adequate oncologic margins in patients with pancreatic ductal adenocarcinoma of the body or tail. 24 However, the hypothesis that alterations in the hematologic and immune systems after splenectomy give rise to increased postoperative complications has prompted a shift toward spleen-preserving DP in patients with benign or low-grade malignant disease. 25, 26 The role of splenic preservation remains controversial. Shoup et al. 27 from Memorial Sloan-Kettering Cancer Center noted that perioperative infectious complications (28% vs. 9%, p=0.01) and other severe complications (11% vs. 2%, p=0.05) were significantly higher with splenectomy compared to splenic preservation. They concluded that spleen-preserving DP can be performed safely with decreased perioperative morbidity. Other authors, however, report little or no benefit to splenic preservation, noting that it is more difficult, takes more time, and increases blood loss. 28, 29 Benoist et al. 30 reported that DP with splenic preservation was associated with increased morbidity when compared to DP with splenectomy. Similarly, in a review of 49 laparoscopic pancreatic resections, Fernández-Cruz et al. 31 noted significantly higher morbidity after laparoscopic DP with splenic preservation compared to laparoscopic DP with splenectomy. Our data suggest no difference in clinical outcomes between spleen-preserving DP and DP with splenectomy with regard to morbidity, pancreatic fistula, and LOS. Our bias is to perform DP with selective spleen preservation when oncologically appropriate.
The LDP patients had fewer overall complications than the ODP patients, but there was no difference in major complication, reoperation, readmission, and mortality rates. As in the literature, our data showed no difference in pancreatic fistula rates between the LDP and ODP groups (11.3% vs. 14.1%, p=0.68). In a case-control comparison of 15 laparoscopic and 15 open patients, for example, Velanovich 11 reported a pancreatic fistula rate of 13% in both groups. Kooby et al. 20 reported pancreatic fistula rates of 26% in 142 patients undergoing LDP and 32% in 200 patients undergoing ODP. Corcione et al. 12 reported an overall pancreatic fistula rate of 10.4% in their series of 19 patients undergoing LDP.
The laparoscopic approach has been shown to yield more rapid recovery and shorter hospitalizations in the treatment of several surgical diseases including colon cancer, cholecystitis, and appendicitis. 9, 12 Our data echo the recent literature and suggest the same is true for select pancreatic disease. 16, 18, 32 When compared to ODP, the LDP group had statistically significant shorter hospital stays with markedly fewer patients staying longer than 5 days.
Our study's main limitation is its retrospective nature. Cases more amenable to the laparoscopic approach were specifically selected, and without randomization, our data reflect an inherent selection bias. Likewise, known cases of adenocarcinoma and suspected complex cases were routinely performed via laparotomy. Studies have shown that adenocarcinoma of the tail of the pancreas has a lower resectability rate than that of the head of the pancreas, likely secondary to patient presentation at a more advanced stage of disease.
11
Local fibrosis and inflammation incited by the tumor make mobilization difficult, and the laparoscopic approach may not allow sufficient regional dissection to perform an oncologically sound operation. 33, 34 Distal pancreatic lesions thus need to be carefully evaluated preoperatively and selected for the laparoscopic approach. Postoperative pathologic examination has revealed successful laparoscopic removal of distal pancreatic adenocarcinoma in several reports, and recent studies suggest LDP for select cases of adenocarcinoma is acceptable provided that surgical margins are not compromised. 35 
Conclusion
Our experience affirms that LDP is a safe and effective option for select cases of distal pancreatic disease. When compared to ODP, successful LDP offers fewer complications and shorter hospital stays. Laparoscopic cases that are converted to open procedures have longer operative times, but clinical outcomes are comparable to conventional DP, supporting an aggressive but judicious use of the laparoscopic approach to DP. Additional research will better determine the role of splenic preservation during DP and clarify the best technique for minimizing pancreatic fistulae from the pancreatic remnant. Finally, further analysis is needed to determine the feasibility, safety, and efficacy of laparoscopic resection of adenocarcinoma of the distal pancreas.
